These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34234874)

  • 61. Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy.
    Deng X; Zheng C; Tang F; Rosol TJ; Shao ZM
    Front Oncol; 2022; 12():1026566. PubMed ID: 36483047
    [No Abstract]   [Full Text] [Related]  

  • 62. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis.
    Huang Y; Hong W; Wei X
    J Hematol Oncol; 2022 Sep; 15(1):129. PubMed ID: 36076302
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4.
    Li Y; Chen P; Zu L; Liu B; Wang M; Zhou Q
    Am J Cancer Res; 2016; 6(2):127-40. PubMed ID: 27186391
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional Role of the microRNA-200 Family in Breast Morphogenesis and Neoplasia.
    Hilmarsdottir B; Briem E; Bergthorsson JT; Magnusson MK; Gudjonsson T
    Genes (Basel); 2014 Sep; 5(3):804-20. PubMed ID: 25216122
    [TBL] [Abstract][Full Text] [Related]  

  • 65. miR-30a/SOX4 Double Negative Feedback Loop is modulated by Disulfiram and regulates EMT and Stem Cell-like properties in Breast Cancer.
    Liu Z; Mi M; Zheng X; Zhang C; Zhu F; Liu T; Wu G; Zhang L
    J Cancer; 2021; 12(16):5053-5065. PubMed ID: 34234874
    [No Abstract]   [Full Text] [Related]  

  • 66. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MiR-212/132 is epigenetically downregulated by SOX4/EZH2-H3K27me3 feedback loop in ovarian cancer cells.
    Lin L; Wang Z; Jin H; Shi H; Lu Z; Qi Z
    Tumour Biol; 2016 Nov; ():. PubMed ID: 27812929
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
    Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
    J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of microRNA-129 on the migration and invasion in NSCLC cells and its mechanism.
    Bin C; Xiaofeng H; Wanzi X
    Exp Lung Res; 2018 Aug; 44(6):280-287. PubMed ID: 30475081
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer.
    Li X; Zhang X; Wu CC; Li PP; Fu YM; Xie LH; Sun SS; Zhou YY; Zhu BL
    J Mol Histol; 2021 Feb; 52(1):21-30. PubMed ID: 33141360
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Conditional knockdown of integrin beta-3 reveals its involvement in osteolytic and soft tissue lesions of breast cancer skeletal metastasis.
    Kovacheva M; Zepp M; Berger S; Berger MR
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):361-371. PubMed ID: 33083904
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cancer statistics, 2020.
    Siegel RL; Miller KD; Jemal A
    CA Cancer J Clin; 2020 Jan; 70(1):7-30. PubMed ID: 31912902
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.
    Ding L; Gu H; Xiong X; Ao H; Cao J; Lin W; Yu M; Lin J; Cui Q
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766744
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.